Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 17 Feb 2026 for Idexx Laboratories INC /de. Read the official filing
Filing timeline
BuySaleMichael Lane
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Michael Lane: trading record in brief
Michael Lane (senior executive) discloses dealings in Idexx Laboratories INC /de to SEC (Form 4). We count 10 filings; the first trade dates from 3 August 2021 and the latest from 14 February 2026.
Every open-market trade on record is a sale: 1 sale worth €439k. Besides market trades, the filings include 9 option exercises.
On 17 February 2026 came the latest disclosure, an option exercise in Idexx Laboratories INC /de. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michael Lane
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
204 shares0Common StockSEC:0000874716-26-000023:0
1,286 shares@ US$206.9423.4% of flowCommon StockSEC:0000874716-25-000125:0
160 shares0Common StockSEC:0000874716-25-000026:0
181 shares0Common StockSEC:0000874716-24-000038:0
462 shares@ US$67.853.5% of flowCommon StockSEC:0000874716-23-000131:0
1,512 shares@ US$141.6023.5% of flowCommon StockSEC:0000874716-23-000103:0
1,000 shares@ US$484.0052.8% of flowCommon StockSEC:0000874716-23-000041:0
196 shares0Common StockSEC:0001567619-23-003218:0
211 shares0Common StockSEC:0001567619-22-004782:0
1,472 shares@ US$67.858.6% of flowCommon StockSEC:0001567619-21-014512:0
10 of 10 declarations
